The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
iwMyeloma 2017 | Identifying the drivers of multiple myeloma
There has been a genome-wide initiative to identify the copy number variants and mutational drivers of multiple myeloma. In this exciting interview, Gareth Morgan, MD, FRCP, FRCPath, PhD, from the UAMS Myeloma Institute, Little Rock, AR, highlights the simplicity yet effectiveness of this initiative for determining prognosis and identifiying high-risk patients. This video was recorded at the Myeloma 2017 meeting in Edinburgh, UK.
